Stock Events

Stock Events

Tarsus Pharmaceuticals (TARS) Q2 2026 Earnings

6MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.73

-0.54

-0.35

-0.16

Details

Expected EPS

-0.400333

Actual EPS

-0.16

Surprise EPS

0.24

Surprise Percent

+60.03%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.16 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.